# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
JP Morgan analyst Lisa Gill maintains Labcorp Holdings (NYSE:LH) with a Overweight and lowers the price target from $261 to ...
Acquisition advances Labcorp's specialty testing strategy in key areas such as oncology and rare diseasesKey milestone reac...
Truist Securities analyst Ryan MacDonald maintains Laboratory Corp (NYSE:LH) with a Buy and lowers the price target from $27...
Barclays analyst Stephanie Davis maintains Laboratory Corp (NYSE:LH) with a Equal-Weight and lowers the price target from $2...
Baird analyst Eric Coldwell maintains Laboratory Corp (NYSE:LH) with a Outperform and lowers the price target from $255 to $...
Labcorp beats Q1 sales estimates, driven by organic growth and acquisitions. Revised 2024 guidance projects higher EPS and sale...